Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06294236
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-02-12
Brief Title:
Study Evaluating SC291 in Subjects With Severe rr B-cell Mediated Autoimmune Diseases GLEAM
Sponsor:
Sana Biotechnology
Organization:
Sana Biotechnology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lupus Erythematosus |
| Systemic Lupus Erythematosus |
| SLE Systemic Lupus |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis |
| Granulomatous Polyangiitis |
| Microscopic Polyangiitis |
Keywords:
| Name | View |
|---|---|
| Vasculitis | View |
| Autoimmune Disease | View |
| Systemic Lupus Erythematosus | View |
| Lupus Nephritis | View |
| Lupus | View |
| Extrarenal Lupus | View |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | View |
| Granulomatous Polyangitis | View |
| Microscopic Polyangiitis | View |
| CAR T Cell Therapy | View |
| Allogeneic | View |
| Hypoimmune | View |
| CD19 | View |
| Cyclophosphamide | View |
| Fludarabine | View |
| Cellular Therapy | View |
| SC291 | View |
| ANCA Associated Vasculitis | View |
| SLE | View |
| ANCA | View |